Camel milk protectiveness toward multiple liver disorders: A review

Area of Science:

• Hepatology and Nutritional Science
• Camel milk's therapeutic potential in liver disease management

Background:

• Liver diseases, including cirrhosis, fatty liver, and hepatitis, pose a significant global health burden.
• Current treatments for liver diseases are often ineffective, carry side effects, and are costly, especially in developing nations.
• Camel milk, rich in nutrients, is traditionally recognized for various health benefits.

Purpose of the Study:

• To systematically review the association between camel milk consumption and liver disease outcomes.
• To evaluate camel milk's impact on laboratory markers and clinical progression of liver disorders, including viral hepatitis, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and hepatocellular carcinoma (HCC).

Main Methods:

• Systematic review of existing studies.
• Evaluation of camel milk's effect on liver function tests (serum gamma-glutamyl transferase, aspartate aminotransferase, alanine aminotransferase).
• Assessment of camel milk's impact on mortality and disease progression in patients with chronic liver disease.

Main Results:

• Camel milk consumption was associated with the modulation of key liver enzyme levels in individuals at risk.
• Patients with chronic liver disease consuming camel milk exhibited lower mortality rates.
• Camel milk consumption correlated with a reduced likelihood of disease progression to cirrhosis.

Conclusions:

• Camel milk demonstrates a therapeutic and preventive role in managing various liver diseases.
• Incorporating camel milk into daily diets may benefit patients with liver disorders.
• Further research into camel milk's mechanisms for improving metabolic regulation and liver health is warranted.